Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Biochemistry,Physiology
Link
http://link.springer.com/article/10.1007/s10456-017-9552-y/fulltext.html
Reference203 articles.
1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
2. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. doi: 10.1016/j.cell.2011.02.013
3. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13(3):206–220. doi: 10.1016/j.ccr.2008.01.034
4. Dulloo I, Phang BH, Othman R, Tan SY, Vijayaraghavan A, Goh LK, Martin-Lopez M, Marques MM, Li CW, de Wang Y, Marin MC, Xian W, McKeon F, Sabapathy K (2015) Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome. Nat Cell Biol 17(4):511–523. doi: 10.1038/ncb3130
5. Gupta N, Duda DG (2016) Role of stromal cell-derived factor 1alpha pathway in bone metastatic prostate cancer. J Biomed Res 30(3):181–185. doi: 10.7555/JBR.30.20150114
Cited by 475 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Circular RNAs in glioma: Molecular functions and pathological implications;Non-coding RNA Research;2024-03
2. Identification of an angiogenesis-related risk score model for survival prediction and immunosubtype screening in multiple myeloma;Aging;2024-02-05
3. Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study;Cancer Management and Research;2024-02
4. The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression;Cancer and Metastasis Reviews;2024-01-19
5. Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis;Frontiers in Pharmacology;2024-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3